![Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295222000235-ga1.jpg)
Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect
![Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19 Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19](https://www.mdpi.com/cells/cells-09-01876/article_deploy/html/images/cells-09-01876-g001.png)
Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
![Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine](https://www.thelancet.com/cms/asset/43327719-6a33-431f-b355-9c5caf7dcc6a/gr1.jpg)
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine
![Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/79/5/674/F1.large.jpg)
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases
![JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association](https://nationaleczema.org/wp-content/uploads/2021/01/JAK-Image-copy.png)
JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association
![The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage](https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74fdbbdbb891b12a39e36/largeThumb/the-potential-of-jak-stat-pathway-inhibition-as-a-new-treatment-strategy-to-control-cytokine-release-syndrome-in-covid-19.jpg)
The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
![Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease | Journal of Medicinal Chemistry Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.9b01439/asset/images/medium/jm9b01439_0011.gif)
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease | Journal of Medicinal Chemistry
![The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19 - ScienceDirect The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359610120301581-gr1.jpg)
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19 - ScienceDirect
![Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma | Future Medicinal Chemistry Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.16.4/asset/images/medium/figure2.gif)